Survival of Younger Myeloma Patients Influenced by Marriage and Insurance, not Ethnicity, Study Finds
With advances in treatment for multiple myeloma, some studies…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreWith advances in treatment for multiple myeloma, some studies…
Adding Darzalex (daratumumab) to the treatment of multiple myeloma…
Empliciti (elotuzumab), a monoclonal antibody, is approved in both the…
Juno Therapeutics and privately held biotech…
Elotuzumab in combination with bortezomib and dexamethasone prolongs…
The Multiple Myeloma Research Foundation (MMRF) and the…